AB0821 ANXIETY AND DEPRESSION IN PSORIATIC ARTHRITIS (PsA) - PREVALENCE AND IMPACT ON PATIENT REPORTED OUTCOMES: REAL-WORLD SURVEY IN THE US AND EUROPE
Laure Gossec(Inserm), Alexis Ogdie(University of Pennsylvania), Elizabeth Holdsworth(Adelphi Group (United Kingdom)), Jessica A. Walsh(VA Salt Lake City Healthcare System), Kaleb Michaud(The National Databank for Rheumatic Diseases), Sara Bruce Wirta(Novartis (Switzerland)), Soumya D. Chakravarty(Johnson & Johnson (United States)), Steve Peterson(Janssen (United States)), Sophie Meakin(London School of Hygiene & Tropical Medicine)
Cited by 1
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study
|The Lancet Infectious Diseases|2020|960
Using a real-world network to model localized COVID-19 control strategies
|Nature Medicine|2020|277
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials
|Annals of the Rheumatic Diseases|2016|275
Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study
|The Lancet Public Health|2021|243